Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Jambolan has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
A rodent study assessed jambolan fruit extract with and without choline against aluminium-induced toxicity, measuring brain and biochemical markers. The combination arm was included specifically because the two were expected to act through partly separate routes. This is animal work on markers rather than outcomes, and it says nothing yet about people.
Jambolan seed and gymnema are the two most commonly paired botanicals in Ayurvedic blood sugar formulas. Stacked, any glucose-lowering effect is additive rather than independent, which matters most for anyone already taking glucose-lowering medication. The practical instruction is to monitor rather than to assume nothing is happening.
Cinnamon produces small reductions in fasting glucose in pooled trial data, and jambolan seed is used traditionally for the same purpose. The effects add, so anyone with blood sugar already managed by medication should track values when starting a combined formula. Neither ingredient replaces medical management.
Berberine activates AMPK and produces meaningful reductions in fasting glucose in human trials, larger than most botanicals. Adding a traditional glucose-directed herb on top means the combined effect can exceed what was intended. This is the pairing in this group most worth flagging for anyone on glucose-lowering medication.
Chromium's role in normal glucose metabolism is an accepted nutritional function, and effects in trials are modest. Combined with a traditional glucose-directed botanical, the direction is the same. Monitoring is sensible, avoidance is not necessarily required.
Deoxynojirimycin in white mulberry inhibits intestinal alpha-glucosidase and blunts the post-meal glucose rise. Jambolan seed extracts have been reported to inhibit the same enzyme class in laboratory assays. Two agents on one enzyme means the post-meal effect can be larger than expected, and the usual consequence of over-inhibition is gas and bloating from unabsorbed carbohydrate.
The astringency of jambolan fruit and seed comes from a high tannin content, and tannin binding of non-heme iron is settled chemistry. An iron supplement swallowed with a jambolan preparation is presented to the intestine in less soluble form. Two hours of spacing removes the issue.
Ellagitannins are not absorbed intact. Gut bacteria hydrolyse them to ellagic acid and then to urolithins, and conversion capacity differs so much between people that a large minority produce almost none. Jambolan supplies precursor; direct urolithin supplementation bypasses the bacterial step entirely.
The deep purple colour of jambolan comes from anthocyanins, which degrade at neutral pH and with oxygen exposure. Acidification is routine in handling anthocyanin-rich fruit powders. This is a stability point about the product rather than a claim about what the pairing does in a person.
Anthocyanins and ellagitannins from jambolan mostly reach the colon intact, where bacteria degrade them into smaller phenolic acids and urolithins. What appears in blood after eating the fruit is mostly those bacterial products. Microbiome composition therefore changes what a person gets from the same dose.
Nothing specific on file for Jambolan. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Jambolan. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.